News & Trends - MedTech & Diagnostics
Roche correcting blood glucose monitor defects
Healthcare professionals and consumers are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters.
It has been identified that Accu-Chek Guide blood glucose meters with serial numbers lower than 92911000001 and Accu-Chek Performa blood glucose meters with serial numbers between 68920000000 and 68925525056 (see image for serial number placement on the back of the meter) may:
- Display E-9 Errors (indicating that the batteries need to be replaced)
- Unexpectedly display the low battery icon
- Have short battery life
- Not power on.
If any of the above issues occur, it can lead to temporary meter unavailability that could cause a delay in therapy decisions, which in turn could lead to a serious medical issue.
The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters
You may also like Injectable, flexible electrode could replace rigid nerve-stimulating implants
Register FREE to receive the latest news and insights from Health Industry Hub – the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - MedTech & Diagnostics
APAC medtech company scores TGA approval in heart disease
MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]
MoreNews & Trends - MedTech & Diagnostics
New state-based pilot to back home-grown medtech innovation
MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]
MoreNews & Trends - Pharmaceuticals
Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis
Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]
MoreNews & Trends - Pharmaceuticals
Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives
Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]
More